Clinical evaluation of contemporary oxygenators. (January 2016)

• Record Type: Journal Article
• Authors: Stanzel, Roger DP; Henderson, Mark
• Is Part Of: Perfusion. Volume 31:Number 1(2016)
• Page Start: 15
• Page End: 25
• Publication Date: 2016-01
• Subjects: cardiopulmonary bypass -- perfusion -- cardiac surgery -- heart-lung machine -- oxygenator -- red blood cells -- platelets -- white blood cells -- neutrophils -- inflammation; Perfusion (Physiology) -- Periodicals; Blood -- Circulation, Artificial -- Periodicals; Heart -- Surgery -- Periodicals; Extracorporeal Circulation -- Periodicals; Perfusion -- Periodicals; Circulation extracorporelle -- Périodiques; Perfusion -- Périodiques; 617.41
• DOI: 10.1177/0267659115604709
• Languages: English
• ISSNs: 0267-6591

Abstract

Advances in cardiopulmonary bypass equipment have played a critical role in improving outcomes for cardiac surgery patients. Recent advancements include reduced priming volumes, biocompatible coatings and gaseous microemboli handling, as well as the incorporation of an arterial filter into the oxygenator. The purpose of this study was to conduct a comprehensive clinical evaluation of adult oxygenators on the market. Oxygenators assessed included the Sorin Synthesis ® (n = 30), the Sorin Inspire 6F ® (n = 10) and Inspire 8F ® (n = 30), the Terumo FX15 ® (n = 13) and FX25 ® (n = 30), the Maquet Quadrox-i ® (n = 30) and the Medtronic Fusion ® (n = 30). Parameters assessed included functional prime volumes, gas exchange, pressure gradients and the effects on patient hematology. The Synthesis had the largest functional prime volume (1426 ml), the FX15 the lowest (956 ml). The Inspire 6F, 8F and Fusion had the greatest O2 transfer. The Sorin oxygenators required the lowest sweep gas flows to obtain a PaCO2 of 40 mmHg. The Sorin oxygenators had the largest pressure gradients. While no differences were observed for hemoglobin and platelet levels post cross-clamp removal, the Sorin Synthesis and Inspire 8F had the largest increases in white blood cell (WBC) counts (122% and 141% of baseline, respectively) and neutrophils (162% and 185% of baseline, respectively). The data demonstrate that no single product is superior in all aspects. The choice of ideal oxygenator depends on the aspect(s) of oxygenator performance the perfusion team believes most clinically acceptable based on available data.